ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
20.77
-0.33 (-1.56%)
Jul 3, 2025, 1:00 PM - Market closed
ArriVent BioPharma Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$39.00
Upside
+87.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +54.07% | Jun 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +111.84% | Jun 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +116.66% | Jun 24, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +92.59% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +92.59% | May 14, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +78.14% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +116.66% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +87.77% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $39 | Strong Buy | Maintains | $36 → $39 | +87.77% | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +73.33% | Nov 15, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +73.33% | Sep 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +87.77% | Sep 10, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $38 | Strong Buy | Maintains | $28 → $38 | +82.96% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +73.33% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +44.44% | Aug 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 | Buy | Reiterates | $35 | +68.51% | Aug 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.